Wiley Bros. Aintree Capital, LLC Zoetis Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 31,880 shares of ZTS stock, worth $5.8 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
31,880
Previous 2,312
1278.89%
Holding current value
$5.8 Million
Previous $391,000
1313.3%
% of portfolio
0.24%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
1,925Shares Held
424MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.5 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.7 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.58 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.94 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.75 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $85.2B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...